GreenLight Biosciences Holdings (GRNA) Research

GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops. Established in 2008, GreenLight Biosciences Holdings is based in Medford, Massachusetts.

Market snapshot

Symbol
GRNA
Price
$0.30
Day change
-0.03%
Market cap
$45.4M
P/E ratio
-0.24x
52-week range
0.177-5.9
Sector
Healthcare
Industry
Biotechnology
Analyst price target
$11.00

Peer companies

  • AlloVir, Inc. (ALVR)
  • bluebird bio, Inc. (BLUE)
  • ERYTECH Pharma S.A. (ERYP)
  • LianBio (LIANY)
  • Magenta Therapeutics, Inc. (MGTA)
  • Pluristem Therapeutics Inc. (PSTI)
  • Lunai Bioworks Inc. (RENB)
  • Rein Therapeutics Inc. (RNTX)

Recent insider activity

  • KODIAK VENTURE PARTNERS III LP — J-Other (9809895 shares) on 2023-07-24
  • KODIAK VENTURE PARTNERS III LP — trade (0 shares) on 2023-05-29
  • Clarke Dennis A. — J-Other (25510.204 shares) on 2023-07-24
  • Anderson Eric Senior — J-Other (25510.204 shares) on 2023-07-24
  • Cummings Foundation, Inc. — J-Other (1275510.2041 shares) on 2023-07-24

Open GreenLight Biosciences Holdings (GRNA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.